Trials / Unknown
UnknownNCT02354846
An Observational Study on Evaluating the Efficacy and Safety of Preemptive Antiviral Therapy With Tenofovir in HBsAg-positive Patients With Diffuse Large B-cell Lymphoma Receiving Rituximab-CHOP Chemotherapy (SPEED Study)
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 112 (estimated)
- Sponsor
- Yonsei University · Academic / Other
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
An Observational Study on Evaluating the Efficacy and Safety of Preemptive Antiviral Therapy with Tenofovir in HBsAg-positive Patients with Diffuse Large B-cell Lymphoma Receiving Rituximab-CHOP Chemotherapy (SPEED study)
Conditions
Timeline
- Start date
- 2015-02-01
- Primary completion
- 2021-03-01
- Completion
- 2021-03-01
- First posted
- 2015-02-03
- Last updated
- 2018-07-17
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02354846. Inclusion in this directory is not an endorsement.